Skip to main content

Microbial diversity

Microbial diversity in coastal Casuarina equisetifolia forest and its potential in counteracting bacterial wilt infections


BACKGROUND


Casuarina wilt is a destructive soil-borne disease caused by Ralstonia solanacearum species complex (RSSC). Recent large-scale outbreaks of Casuarina wilt in the coastal regions of Guangdong Province, China, suggest that the originally resistant Casuarina clones become susceptible to RSSC infection. This study aimed to investigate the microbial diversity of environmental microorganisms and its potential in biocontrol of this devastating disease.

RESULTS


The results unveiled the dominant and common microbial species in Casuarina equisetifolia tree tissues, the rhizosphere soils and seawater in the vicinity of Casuarina equisetifolia forest belt. We also found a range of bacterial species with potent antimicrobial activities against Ralstonia pseudosolanacearum. Both the Casuarina endophyte A1-5, identified as Bacillus velezensis, and a combination biocontrol agent named CEP consisting of three mutually compatible soil isolates belonging to Citrobacter farmeri, Enterobacter aerogenes, and Pseudomonas mosselii, respectively, could effectively control the R. pseudosolanacearum infections on Casuarina and tomato. The active substance of strain A1-5 that inhibits the growth of R. pseudosolanacearum was purified and identified as surfactin C.

CONCLUSION


The findings unveiled the microbial diversity and their specific distributions in the Guangdong coastal Casuarina equisetifolia forest areas, and present useful clues and resources for developing new strategies to prevent and control the Casuarina bacterial wilt. © 2025 Society of Chemical Industry.

bacterial infection, viral infection, fungal infection, parasitic infection, antimicrobial resistance, contagious diseases, infectious disease prevention, sepsis, nosocomial infections, zoonotic diseases, immune response, vaccination, epidemic, pandemic, outbreak control, pathogen, incubation period, transmission routes, asymptomatic carriers, infection control

#InfectionControl, #AntibioticResistance, #PublicHealth, #DiseasePrevention, #ViralInfection, #BacterialInfection, #FungalInfection, #InfectiousDiseases, #PandemicPreparedness, #VaccinesWork, #SepsisAwareness, #HygieneMatters, #ContagiousDiseases, #ZoonoticInfections, #HospitalInfections, #GlobalHealth, #HealthSecurity, #InfectionPrevention, #PathogenAlert, #StopTheSpread


International Conference on Genetics and Genomics of Diseases

Visit: genetics-conferences.healthcarek.com

Award Nomination: genetics-conferences.healthcarek.com/award-nomination/?ecategory=Awards&rcategory=Awardee

Award registration: genetics-conferences.healthcarek.com/award-registration/

For Enquiries: contact@healthcarek.com

Get Connected Here
---------------------------------
---------------------------------
in.pinterest.com/Dorita0211
twitter.com/Dorita_02_11_
facebook.com/profile.php?id=61555903296992
instagram.com/p/C4ukfcOsK36
genetics-awards.blogspot.com/
youtube.com/@GeneticsHealthcare

Comments

Popular posts from this blog

Fruitful innovation

Fruitful innovation: Transforming watermelon genetics with advanced base editors The development of new adenine base editors (ABE) and adenine-to-thymine/ guanine base editors (AKBE) is transforming watermelon genetic engineering. These innovative tools enable precise A:T-to-G and A:T-to-T base substitutions, allowing for targeted genetic modifications. The research highlights the efficiency of these editors in generating specific mutations, such as a flowerless phenotype in ClFT (Y84H) mutant plants. This advancement not only enhances the understanding of gene function but also significantly improves molecular breeding, paving the way for more efficient watermelon crop improvement. Traditional breeding methods for watermelon often face challenges in achieving desired genetic traits efficiently and accurately. While CRISPR/Cas9 has provided a powerful tool for genome editing, its precision and scope are sometimes limited. These limitations highlight the need for more advanced gene-e...

Genetic factors with clinical trial stoppage

Genetic factors associated with reasons for clinical trial stoppage Many drug discovery projects are started but few progress fully through clinical trials to approval. Previous work has shown that human genetics support for the therapeutic hypothesis increases the chance of trial progression. Here, we applied natural language processing to classify the free-text reasons for 28,561 clinical trials that stopped before their endpoints were met. We then evaluated these classes in light of the underlying evidence for the therapeutic hypothesis and target properties. We found that trials are more likely to stop because of a lack of efficacy in the absence of strong genetic evidence from human populations or genetically modified animal models. Furthermore, certain trials are more likely to stop for safety reasons if the drug target gene is highly constrained in human populations and if the gene is broadly expressed across tissues. These results support the growing use of human genetics to ...

Genetics study on COVID-19

Large genetic study on severe COVID-19 Bonn researchers confirm three other genes for increased risk in addition to the known TLR7 gene Whether or not a person becomes seriously ill with COVID-19 depends, among other things, on genetic factors. With this in mind, researchers from the University Hospital Bonn (UKB) and the University of Bonn, in cooperation with other research teams from Germany, the Netherlands, Spain and Italy, investigated a particularly large group of affected individuals. They confirmed the central and already known role of the TLR7 gene in severe courses of the disease in men, but were also able to find evidence for a contribution of the gene in women. In addition, they were able to show that genetic changes in three other genes of the innate immune system contribute to severe COVID-19. The results have now been published in the journal " Human Genetics and Genomics Advances ". Even though the number of severe cases following infection with the SARS-CoV-...